Paul G. Abrams

Direktor/Vorstandsmitglied bei Geneius Biotechnology, Inc.

Health Technology

Commercial Services

Profil

Paul G.
Abrams is currently the Executive Director at Geneius Biotechnology, Inc. He was previously the President & Chief Executive Officer at Poniard Pharmaceuticals, Inc. from 1990 to 2001.
He also served as the President & Chief Executive Officer at CEPTYR, Inc.

Aktive Positionen von Paul G. Abrams

Unternehmen	Position	Beginn
Geneius Biotechnology, Inc. Geneius Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Geneius Biotechnology, Inc. operates as an immuno-oncology company. It develops autologous, adoptive T cell therapy technology which generates robust immune response to cancer. The company was founded by Alfred E. Slanetz in 2015 and is headquartered in Natick, MA.	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Paul G. Abrams

Ehemalige bekannte Positionen von Paul G. Abrams

Unternehmen	Position	Ende
PONIARD PHARMACEUTICALS, INC.	Vorstandsvorsitzender	31.07.2001
CEPTYR, Inc. CEPTYR, Inc. Pharmaceuticals: MajorHealth Technology CEPTYR, Inc. developed pharmaceutical products. The company was founded by George Rathmann & Deborah Cool in 1995 and was headquartered in Redmond, WA.	Präsident	-

Sehen Sie sich die Erfahrung von Paul G. Abrams im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Paul G. Abrams im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
PONIARD PHARMACEUTICALS, INC.	Health Technology

Private Unternehmen	2
CEPTYR, Inc. CEPTYR, Inc. Pharmaceuticals: MajorHealth Technology CEPTYR, Inc. developed pharmaceutical products. The company was founded by George Rathmann & Deborah Cool in 1995 and was headquartered in Redmond, WA.	Health Technology
Geneius Biotechnology, Inc. Geneius Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Geneius Biotechnology, Inc. operates as an immuno-oncology company. It develops autologous, adoptive T cell therapy technology which generates robust immune response to cancer. The company was founded by Alfred E. Slanetz in 2015 and is headquartered in Natick, MA.	Commercial Services

Sehen Sie sich die Unternehmensverbindungen an

Börse
Insiders
Paul G. Abrams